Ondansetron
Product Description
Jiangsu Hengrui Medicine Co., Ltd.
-
CN
-
2015On CPHI since
-
2Certificates
-
5000+Employees
Company types
Specifications
Jiangsu Hengrui Medicine Co., Ltd.
-
CN
-
2015On CPHI since
-
2Certificates
-
5000+Employees
Company types
More Products from Jiangsu Hengrui Medicine Co., Ltd. (99)
-
Product Dexmedetomidine HCl Injection
Dexmedetomide HCl is an anxiolytic, sedative, andanalgesic medication.
Strength: 200mcg/2ml (100mcg/ml); Single-dose Vial
This product has been approved by CFDA and US-FDA.
Strength: 80mcg/20ml; 200mcg/50ml; 400mcg/100ml
This product has been app... -
Product Atracurium Besylate
Atracurium besylate is a neuromuscular-blocking drug or skeletal muscle relaxant in the category of non-depolarizing neuromuscular-blocking drugs, used adjunctively in anesthesia to facilitate endotracheal intubation and to provide skeletal muscle relaxatio... -
Product Butorphanol Tartrate
Butorphanol Tartate is a morphinan-type synthetic opioid analgesic.
It is approved by NMPA. -
Product Salmeterol xinafoate + Fluticasone propionate
It is indicated for asthma.It is still in R&D stage. -
Product Sugammadex Sodium
Sugammadex is a selective relaxant binding agent indicated for reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide during surgery in adults.It is still in R&D stage and estimated to be approved by 2020. -
Product Paricalcitol
Paricalcitol is a synthetic vitamin D analogue. Paricalcitol has been used to reduce parathyroid hormone levels. It is still in R&D stage, and estimated to be approved by 2020. -
Product Febuxostat
Febuxostat is a xanathine oxidase (XO) inhibitor indicated in patients with gout suffering from hyperuricemia and is used in its chronic management.It is still in R&D stage and estimated to be approved by 2020. -
Product Capecitabine
Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of numerous cancers. It is a prodrug that is enzymatically converted to 5-fluorouracil (5-FU) in the body.
It is approved by NMPA. -
Product Caspofungin Acetate
Caspofungin Acetate is a lipopeptide antifungal drug. It is a member of a new class of antifungals termed the echinocandins. It works by inhibiting the enzyme (1→3)-β-D-glucan synthase and thereby disturbing the integrity of the fungal cell wall. Caspofungin was the ... -
Product Celecoxib
Celecoxib is a COX-2 selective nonsteroidal anti-inflammatory drug (NSAID). It is used to treat the pain and inflammation of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute pain in adults, painful menstruation, and juvenile rheumatoid arthrit... -
Product Cisatracurium Besylate
Cisatracurium Besylate is a bisbenzyltetrahydroisoquinolinium that has effect as a neuromuscular-blocking drug or skeletal muscle relaxant in the category of non-depolarizing neuromuscular-blocking drugs, used adjunctively inanesthesia to facilitate endotracheal intubation&nbs... -
Product Clopidogrel Bisulfate
Clopidogrel Bisulfate is a by mouth, thienopyridine-class antiplatelet agentused to inhibit blood clots in coronary artery disease, peripheral vascular disease, cerebrovascular disease, and to prevent heart attack and stroke. The drug works by irreversibly inhibiting...
Jiangsu Hengrui Medicine Co., Ltd. resources (1)
-
Brochure Hengrui Medicine - Company Details
Hengrui Medicine is dedicated to research, developing, and promoting innovative medicine with high quality.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance